The protocol at a glance
There is no human dose or schedule in any source I found.
| Item | What the sources show |
|---|---|
| Human dose | Not established |
| Studied in | Rat tissue cultures and cultured cells from older people |
Prostamax is not the same as Prostatilen, a prostate extract product that the Russian group lists separately in its clinical review. ClinicalTrials.gov lists no Prostamax trial (searched 5 Nov 2026).
Community notes report 500 mcg to 1 mg a day for 10 to 20 days. These are user reports, not trial data.
What people say they do, collected from community discussions. Not tested in a trial; shown so you can compare it with the evidence above.
Mixing
No mixing table here: this one is used as a capsule, nasal spray or skin product, or has no human amount to calculate from. The general mixing calculator works for any vial.
What the trials found
No treatment results in people exist. Lab findings:
Adv Gerontol 2006 (PMID 17152728); Georgian Med News 2012 (PMID 23221144).
Side effects
- No human safety data exists.
How it works
Chromatin loosening (lab)
In cells from older people it loosened tightly packed DNA (heterochromatin). This is a lab finding only.
Sources
- Tissue-specific effect of synthetic peptides in organotypic culture. Adv Gerontol 2006, PMID 17152728
- Deheterochromatinization in old age induced by Prostamax. Georgian Med News 2012, PMID 23221144
- Khavinson VKh, Kuznik BI, Ryzhak GA. Adv Gerontol 2014 (clinical review; lists Prostatilen, not Prostamax)
- ClinicalTrials.gov search by intervention name, run 5 Nov 2026: 0 results